Skip to main content

Rh immunoglobulin (Rhogam) for Rh negative pregnant women at risk of fetal blood exposure.

CBE ID
0652
1.4 Project
National Voluntary Consensus Standards for Ambulatory Care: Additional Outpatient Measures
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2010
Is Under Review
No
1.3 Measure Description

Percent of Rh negative pregnant women at risk of fetal blood exposure who receive Rhogam the ED.

    • 1.14 Numerator

      Number of appropriate patients who receive Rhogam in the ED.

    • 1.15 Denominator

      All women, confirmed pregnant, who are at significant risk of fetal blood exposure, including:
      1. those diagnosed with an ectopic pregnancy
      2. those in the second or third trimester:
      a: with a threatened abortion (threatened, partial, complete, or spontaneous)
      b. those who report or are found to have significant vaginal bleeding (not just spotting)
      c. those who have sustained blunt abdominal trauma
      3. those who undergo an invasive obstetric procedure in the ED (genetic amniocentesis; chorion villus sampling; fetal blood sampling, D&C).

    • Exclusions

      1. Patient refusal
      2. Patients who have received appropriate Rh immunoglobulin previously
      3. OB/GYN consultation documenting Rh immunoglobulin not recommended

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed National Voluntary Consensus Standards for Ambulatory Care: Additional Outpatient Measures 2010
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      American College of Emergency Physicians
      Steward Organization POC Email
      [email protected]
      Steward Organization Copyright

      None